If you're focusing on this Category and want to learn from the best, then check out the content we have for you.
Talks related to Solid Tumors: Immuno-Oncology & Novel Therapeutics
20
Overcoming Tumor Antigen Heterogeneity in the Context of CAR T Cell therapy for Solid Tumors
20
Tumor Endothelial Cells in NSCLC: headmasters of tumor immunity
20
Modeling Therapy-Induced Tumor Cell State Plasticity to Identify Vulnerabilities for Reducing Disease Burden
20
Cracking open the undruggable RAS: A Clinical Perspective
20
Development of a novel biodegradable chemo-radioembolic formulation for transarterial treatment of hepatocellular carcinoma
21
Combination of integrated genomics with ex vivo microcancer drug screens to individualize brain cancer therapy
21
Age of combination therapy in the treatment of advanced RCC: can we do it better?
21
Proteomic and N-glycome profiling of secretome from BRAFV600E mutant colon cancer cells with acquired resistance to vemurafenib
22
Investigating protein- and gene-expression of 27 cytokines/chemokines in melanoma patients. Identification of a 4-genes signature
22
MET as a druggable target in solid tumors
22
Flexible samarium-153 radiotherapeutic bandage for radiation therapy of skin cancer
22
Ion channel drugs as electroceuticals for reprogramming cancer: exploiting bioelectric controls of cell and tissue function
23
Two retrospective studies on gender differences: chemotherapy toxicities in patients affected by colorectal and pancreatic cancers
23
Designing a Multi-Epitope Vaccine Against Cancer-Testis Antigens in Non-Small Cell Lung Cancer: an In Silico Approach
24
Advanced ovarian cancer: exploiting exosomes to potentiate the anti-cancer immune response
24
Imaging of tumor acidosis for monitoring response to novel anticancer therapies
24
Solid Tumors: Immuno-Oncology
25
Cancer therapy potential: molecular characterization of Lucilia sericata angiopoietin-1 | Poster Talk
26
Apocrine breast carcinoma from biomarkers to therapy
26